Cleared Traditional

K941604 - VENTANA ANTI-CD4 PRIMARY ANTIBODY (FDA 510(k) Clearance)

Feb 1997
Decision
1050d
Days
Class 2
Risk

K941604 is an FDA 510(k) clearance for the VENTANA ANTI-CD4 PRIMARY ANTIBODY. This device is classified as a Lambda, Antigen, Antiserum, Control (Class II - Special Controls, product code DEH).

Submitted by Ventana Medical Systems, Inc. (Tucson, US). The FDA issued a Cleared decision on February 14, 1997, 1050 days after receiving the submission on April 1, 1994.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5550.

Submission Details

510(k) Number K941604 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 01, 1994
Decision Date February 14, 1997
Days to Decision 1050 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code DEH — Lambda, Antigen, Antiserum, Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5550